Takao et al., Am J Nephrol 2009
(Albuminuria) :
Human albumin ( 0.1-10 mg/ml ) dose-dependently increased NAG release and olmesartan or valsartan ( 10 ( -9 ) -10 ( -7 ) mol/l ) showed a significant reduction on albumin ( 1 mg/ml ) -induced NAG release in RPTEC
McMillan et al., J Rheumatol 1981
(Gout) :
However, albumin prevented enhancement of NAG release by IgG